Partner Winston Kirton serves as co-chair of the 2024 FDLI Annual Conference, May 15-16, 2024, in Washington, D.C. and will take part in the welcome and introductions as well as moderate the panel “Modernizing Clinical Trials: Improving Diversity and Efficiency While Maintaining High Standards.”
Partner Lee Rosebush addresses “The State of Drug Compounding: Looking Back to Look Forward.” He will be joined on the panel by Gail Bormel, Director of the Office of Compounding Quality and Compliance, CDER, FDA. The conference for the food and drug law community provides an opportunity to examine the complex legal, regulatory, compliance and policy issues currently impacting the FDA-regulated industry.